Objective To assess the clinical efficacy and safety of rectal mucosal columnar suturing(Block technique)in combination with lauromacrogol injection for the treatment of female rectocele.Methods This retro-spective study analyzed 90 female patients with rectocele who were treated at Sir Run Run Hospital,Nanjing Medical University,from January 2022 to December 2023.Patients were categorized into three groups according to their surgical treatments:Block combined with lauromacrogol injection(BP group,n=30),Block alone(B group,n=30),and Procedure for Prolapse and Hemorrhoids(PPH,H group,n=30).The study compared general clinical data,perioperative indicators,Longo′s Obstructed Defecation Syndrome(Longo′s ODS)scores,the degree of recto-cele before and after surgery,anorectal manometry parameters,surgical efficacy,and perioperative complications among the three groups.Results The intraoperative blood loss in Group H was significantly higher compared to Groups B and BP(P<0.05).In terms of the 24-hour postoperative VAS score and hospital stay duration,Group BP demonstrated superior outcomes relative to Groups H and B(P<0.05).Preoperatively,there were no significant differences among the three groups regarding Longo′s ODS score,rectocele depth,resting anal pressure,or residual anal pressure(P>0.05).Postoperatively,Group BP exhibited significantly better Longo′s ODS scores and rectocele depth compared to Groups B and H(P<0.05).Although no significant differences were observed in postoperative resting and residual anal pressures among the three groups(P>0.05),the values in Group BP were closer to the normal range.The overall efficacy rate in Group BP was 93.3%,which was higher than the 73.3%in Group B and 66.7%in Group H(P<0.05).There was no significant difference in the complication rate across the three groups(P>0.05).Conclusions Block combined with lauromacrogol injection is a safe and effective treatment for female rectocele,demonstrating superior efficacy compared to both PPH and Block alone.This method not only effectively restores the physiological anatomy of the female rectum but also significantly improves clinical symptoms.

Objective:To establish a quality standard for the bacterial endotoxin test method of fructose sodium diphosphate injections(FDP injections),so as to provide reference for the formulation and revision of the national standard for this drug.Methods:The interference test and bacterial endotoxins test of 22 batch samples of FDP in-jections from nine manufacturers were performed with TALs,and the bacterial endotoxins of samples were tested and the results were judged.Results:A bacterial endotoxin limit value of 0.72 EU·mg-1 for fructose sodium diphos-phate was established,which was suitable for 22 batches of FDP injections met the requirements.Conclusion:The bacterial endotoxin test method established in this study can be used to substitute the rabbit pyrogen test and meet the quality control requirements of FDP injections.

Objective:To establish a quality standard for the bacterial endotoxin test method of fructose sodium diphosphate injections(FDP injections),so as to provide reference for the formulation and revision of the national standard for this drug.Methods:The interference test and bacterial endotoxins test of 22 batch samples of FDP in-jections from nine manufacturers were performed with TALs,and the bacterial endotoxins of samples were tested and the results were judged.Results:A bacterial endotoxin limit value of 0.72 EU·mg-1 for fructose sodium diphos-phate was established,which was suitable for 22 batches of FDP injections met the requirements.Conclusion:The bacterial endotoxin test method established in this study can be used to substitute the rabbit pyrogen test and meet the quality control requirements of FDP injections.

To analyze the epidemiological characteristics of COVID-19 in Fujian Province from the 49th week of 2022 to the 5th week of 2023,after further optimization of China's COVID-19 prevention and control measures on December 7,2022(the 49th week of 2022),this study used multi-dimensional surveillance data to dynamically assess population infection levels and their changing trends.The aim of the study was to provide a scientific basis for early warning of epidemic risk,medical resource allocation,and evalu-ation of socio-economic impact.A multi-source data surveillance system was constructed,encompassing surveillance of fever clinics at medical institutions(weekly collection of visits,positive nucleic acid and antigen test results,inpatients,and severe cases in sec-ondary or above hospitals),population nucleic acid test monitoring(weekly person-times and positivity rates of single-tube tests from the provincial system),sentinel hospital monitoring(weekly proportion of influenza-like illness visits at 18 sentinel hospitals and re-lated viral testing data),and monitoring of novel coronavirus variants(weekly systematic collection of genomic sequences of local and imported cases).Line charts were plotted weekly,and time series analysis,molecular epidemiological methods,and an improved SEIAR model were used to simulate epidemic spread.During the study period,the COVID-19 epidemic in Fujian Province exhibited three distinct stages.In the infection peak stage(52nd week of 2022),the provincial fever clinic visits reached 606 893 person-times,and a 49.2%positivity rate in population single-tube nucleic acid tests and 63.8%positivity rate in sentinel hospital monitoring were observed.In the medical load peak stage(2nd week of 2023),274 460 inpatients and 28 487 severe cases were recorded.In the epidemic decline stage(4th to 5th weeks of 2023),fever clinic visits decreased by 96.3%with respect to the peak,the single-tube nucleic acid test positivity rate decreased to 6.3%,and the sentinel hospital COVID-19 nucleic acid test positivity rate was 6.4%.All 508 sequenced local cases were Omicron variants,predominantly BA.5.2 and its sub-lineages(67.4%).Among 56 imported se-quenced cases,BA.5.2 and its sub-lineages accounted for 50.0%,and 16.1%comprised nine variants of interest including XBB and BQ.The model predicted the infection peak in the 52nd week of 2022,whereas the hospitalization peak lagged by approximately 10.6 days.Multi-source data monitoring revealed a three-stage development of the COVID-19 epidemic in Fujian.The BA.5.2 strain was dominant during the epidemic.The combination of multi-source monitoring data and modeling provides important references for epi-demic prevention and control,and highlights the need to improve the monitoring system in follow-up.

Objective To investigate the impact of Epstein-Barr virus(EBV)infection on immune responses among systemic lupus erythematosus(SLE)patients.Methods AA total of 103 SLE patients(SLE group),50 rheumatoid arthritis(RA)patients(RA group),and 120 healthy physical examinees(control group)were enrolled from May 2022 to April 2024.Anti-EBV CA IgG,IgA,IgM,anti-EBV EA IgM,and anti-EBV NA IgG,IgA antibody levels were measured using direct chemiluminescent magnetic particle-based indirect immunoassay,and positive rates were compared among groups.SLE patients were further divided into reactivated infection and past infection groups based on anti-EBV antibody profiles.Non-specific and specific immune response markers were assessed.Peripheral blood T lymphocytes from two groups were isolated via fluorescence-activated cell sorting(FACS)for transcriptomic sequencing.Results The positive rate of anti-EBV CA IgA antibody in the SLE group[22.30％(23/103)]was higher than that in the RA group[6.00％(3/50)]and the control group[5.00％(6/120)],showing significant difference(P＜0.05).In SLE patients,anti-EBV EA IgM antibody was positively correlated with interferon-α(IFN-α)(r=0.1984,P＜0.05);anti-EBV CA IgM antibody was positively correlated with interleukin(IL)-2,IL-5,and IL-1β(r=0.1980,0.2553,0.1797,P＜0.05);anti-EBV CA IgG antibody was positively correlated with IL-5(r=0.2769,P＜0.05),IL-2(r=0.1820,P＜0.05),IL-8(r=0.1920,P＜0.05),and interferon-γ(IFN-γ)(r=0.1807,P＜0.05).Anti-EBV NA IgG antibody was positively correlated with IL-4(r=0.2015,P＜0.05),IL-8(r=0.2395,P＜0.05),and IL-17(r=0.1795,P＜0.05),and negatively correlated with IL-5(r=-0.2212,P＜0.05).Anti-EBV NA IgG antibody in SLE patients was positively correlated with IgG(r-0.2731,P＜0.05),and anti-EBV CA IgM antibody was positively correlated with IgM(r=0.2614,P＜0.05);anti-EBV EA IgM antibody was negatively correlated with white blood count(r=-0.2742,P＜0.05),neutrophil count(r=-0.2249,P＜0.05),lymphocyte count(r=-0.2723,P＜0.05),and monocyte count(r=-0.2275,P＜0.05),and anti-EBV NA IgA antibody was positively correlated with IgA results(r=0.3231,P＜0.05).The anti-EBV CA IgA antibody-positive SLE group showed elevated levels of the nonspecific immune response marker IgA and decreased levels of C3 and C4,as compared with the anti-EBV CA IgA antibody-negative SLE group,RA group,and control group(P＜0.05).Additionally,when compared with the RA group and control group,the anti-EBV CA IgA antibody-positive SLE group had reduced specific immune response parameters,including CD16+56+,CD 19,and the CD4/CD8 ratio(P＜0.05).Results from transcriptomic sequencing of peripheral blood T lymphocytes revealed upregulation of IL-2,IL-5,IL-8 and IFN-γ in reactivated infection group,as compared with the past infection group(P＜0.05).Results of the differential gene enrichment analysis between the two groups revealed that the differentially expressed genes were primarily associated with inflammatory signaling pathways,such as"inflammatory response activation,""inflammasome formation,"and"inflammatory cytokine release."Conclusion SLE patients demonstrate higher EBV activity.EBV infection may exacerbate SLE's inflammatory microenvironment by activating Th1/Th2 immune responses and promote humoral immune activation.

Objective To compare the effects of different doses of budesonide and formoterol fumarate powder for inhalation combined with montelukast sodium tablet in the treatment of cough variant asthma(CVA)and the improvement of airway function and inflammatory factors.Methods Elderly patients with cough variant asthma were randomly divided into group A and group B.Both groups of patients received budesonide and formoterol fumarate powder for inhalation combined with montelukast sodium tablet.Group A was given budesonide and formoterol fumarate powder for inhalation(Ⅱ),2 inhalation per time,twice a day;Group B was given budesonide and formoterol fumarate powder for inhalation,4 inhalation per time,twice a day;budesonide fumatrol inhalation powder mist for continuous treatment for 6 months,and montelukast sodium tablet 10 mg once a day for at least 3 months.The nighttime cough scores of the two groups were compared before treatment and after treatment.The percentage of forced expiratory volume in one second(FEV1)in the predicted value,the maximum mid expiratory flow(MMEF),the fractional exhaled nitric oxide(FeNO),interleukin-5(IL-5)and eosinophils were compared between the two groups.The incidence of adverse drug reactions and the recurrence rate within 1 year were compared between the two groups.Results A total of 45 cases were enrolled in both the group A and the group B.At 9 months after treatment,the nocturnal cough scores of the group A and the group B were(0.93±0.42)and(0.65±0.29)points,respectively;the percentage of FEV1 in the predicted value were(97.75±9.67)％and(100.93±11.06)％,respectively;the MMEF values were(2.81±1.04)and(3.08±1.09)L·s-1,respectively;the FeNO values were(18.94±9.75)and(15.94±7.96)ppb,respectively;the IL-5 levels were(10.88±7.06)and(8.11±5.56)pg·mL-1,respectively.The above indicators in group B showed statistically significant differences compared to group A(all P＜0.05).The total incidence of adverse drug reactions in group A and group B were 8.89％(5 cases/45 cases)and 13.33％(6 cases/45 cases),respectively.The recurrence rates was 15.56％(7 cases/45 cases)and 13.33％(6 cases/45 cases),respectively.There was no statistically significant difference in the above indicators between group B and group A(all P＞0.05).Conclusion For elderly patients with CVA,higher dose of budesonide and formoterol fumarate powder for inhalation combined with montelukast sodium tablet can better improve cough symptoms,reduce the level of airway hyperresponsiveness and inflammatory factors,reduce the recurrence rate,and the patients are well tolerated.

Objective To investigate the impact of Epstein-Barr virus(EBV)infection on immune responses among systemic lupus erythematosus(SLE)patients.Methods AA total of 103 SLE patients(SLE group),50 rheumatoid arthritis(RA)patients(RA group),and 120 healthy physical examinees(control group)were enrolled from May 2022 to April 2024.Anti-EBV CA IgG,IgA,IgM,anti-EBV EA IgM,and anti-EBV NA IgG,IgA antibody levels were measured using direct chemiluminescent magnetic particle-based indirect immunoassay,and positive rates were compared among groups.SLE patients were further divided into reactivated infection and past infection groups based on anti-EBV antibody profiles.Non-specific and specific immune response markers were assessed.Peripheral blood T lymphocytes from two groups were isolated via fluorescence-activated cell sorting(FACS)for transcriptomic sequencing.Results The positive rate of anti-EBV CA IgA antibody in the SLE group[22.30％(23/103)]was higher than that in the RA group[6.00％(3/50)]and the control group[5.00％(6/120)],showing significant difference(P＜0.05).In SLE patients,anti-EBV EA IgM antibody was positively correlated with interferon-α(IFN-α)(r=0.1984,P＜0.05);anti-EBV CA IgM antibody was positively correlated with interleukin(IL)-2,IL-5,and IL-1β(r=0.1980,0.2553,0.1797,P＜0.05);anti-EBV CA IgG antibody was positively correlated with IL-5(r=0.2769,P＜0.05),IL-2(r=0.1820,P＜0.05),IL-8(r=0.1920,P＜0.05),and interferon-γ(IFN-γ)(r=0.1807,P＜0.05).Anti-EBV NA IgG antibody was positively correlated with IL-4(r=0.2015,P＜0.05),IL-8(r=0.2395,P＜0.05),and IL-17(r=0.1795,P＜0.05),and negatively correlated with IL-5(r=-0.2212,P＜0.05).Anti-EBV NA IgG antibody in SLE patients was positively correlated with IgG(r-0.2731,P＜0.05),and anti-EBV CA IgM antibody was positively correlated with IgM(r=0.2614,P＜0.05);anti-EBV EA IgM antibody was negatively correlated with white blood count(r=-0.2742,P＜0.05),neutrophil count(r=-0.2249,P＜0.05),lymphocyte count(r=-0.2723,P＜0.05),and monocyte count(r=-0.2275,P＜0.05),and anti-EBV NA IgA antibody was positively correlated with IgA results(r=0.3231,P＜0.05).The anti-EBV CA IgA antibody-positive SLE group showed elevated levels of the nonspecific immune response marker IgA and decreased levels of C3 and C4,as compared with the anti-EBV CA IgA antibody-negative SLE group,RA group,and control group(P＜0.05).Additionally,when compared with the RA group and control group,the anti-EBV CA IgA antibody-positive SLE group had reduced specific immune response parameters,including CD16+56+,CD 19,and the CD4/CD8 ratio(P＜0.05).Results from transcriptomic sequencing of peripheral blood T lymphocytes revealed upregulation of IL-2,IL-5,IL-8 and IFN-γ in reactivated infection group,as compared with the past infection group(P＜0.05).Results of the differential gene enrichment analysis between the two groups revealed that the differentially expressed genes were primarily associated with inflammatory signaling pathways,such as"inflammatory response activation,""inflammasome formation,"and"inflammatory cytokine release."Conclusion SLE patients demonstrate higher EBV activity.EBV infection may exacerbate SLE's inflammatory microenvironment by activating Th1/Th2 immune responses and promote humoral immune activation.

To analyze the epidemiological characteristics of COVID-19 in Fujian Province from the 49th week of 2022 to the 5th week of 2023,after further optimization of China's COVID-19 prevention and control measures on December 7,2022(the 49th week of 2022),this study used multi-dimensional surveillance data to dynamically assess population infection levels and their changing trends.The aim of the study was to provide a scientific basis for early warning of epidemic risk,medical resource allocation,and evalu-ation of socio-economic impact.A multi-source data surveillance system was constructed,encompassing surveillance of fever clinics at medical institutions(weekly collection of visits,positive nucleic acid and antigen test results,inpatients,and severe cases in sec-ondary or above hospitals),population nucleic acid test monitoring(weekly person-times and positivity rates of single-tube tests from the provincial system),sentinel hospital monitoring(weekly proportion of influenza-like illness visits at 18 sentinel hospitals and re-lated viral testing data),and monitoring of novel coronavirus variants(weekly systematic collection of genomic sequences of local and imported cases).Line charts were plotted weekly,and time series analysis,molecular epidemiological methods,and an improved SEIAR model were used to simulate epidemic spread.During the study period,the COVID-19 epidemic in Fujian Province exhibited three distinct stages.In the infection peak stage(52nd week of 2022),the provincial fever clinic visits reached 606 893 person-times,and a 49.2%positivity rate in population single-tube nucleic acid tests and 63.8%positivity rate in sentinel hospital monitoring were observed.In the medical load peak stage(2nd week of 2023),274 460 inpatients and 28 487 severe cases were recorded.In the epidemic decline stage(4th to 5th weeks of 2023),fever clinic visits decreased by 96.3%with respect to the peak,the single-tube nucleic acid test positivity rate decreased to 6.3%,and the sentinel hospital COVID-19 nucleic acid test positivity rate was 6.4%.All 508 sequenced local cases were Omicron variants,predominantly BA.5.2 and its sub-lineages(67.4%).Among 56 imported se-quenced cases,BA.5.2 and its sub-lineages accounted for 50.0%,and 16.1%comprised nine variants of interest including XBB and BQ.The model predicted the infection peak in the 52nd week of 2022,whereas the hospitalization peak lagged by approximately 10.6 days.Multi-source data monitoring revealed a three-stage development of the COVID-19 epidemic in Fujian.The BA.5.2 strain was dominant during the epidemic.The combination of multi-source monitoring data and modeling provides important references for epi-demic prevention and control,and highlights the need to improve the monitoring system in follow-up.

Objective To evaluate the effects of bladder neck preservation on postoperative stress urinary inconti-nence and retrograde ejaculation in patients undergoing transurethral thulium laser enucleation of the prostate(ThuLEP).Methods The clinical data of 203 patients who underwent ThuLEP in our hospital from September 2021 to December 2023 were retrospectively analyzed.According to the operation method,the patients were divided into bladder neck preservation group(n=95)and non-bladder neck preservation group(n=108).The occurrence of postoperative stress urinary inconti-nence and retrograde ejaculation of the two groups were compared.Results The differences between the patients of two groups in operative time(110[80,130]min vs 110[90,140]min),hospital stay(8[8,8]d vs 8[8,8]d),in-dwelling catheter time(7[7,7]h vs 7[7,7]h),and hemoglobin decline(9[6,14]g/L vs 8[4,13]g/L)were not statistically significant(P＞0.05).There were no statistically significant differences between the two groups at 3 months postoperatively in maximum flow rate(20[18,21]mL/s vs 19[18,20]mL/s),scores of International Prostate Symp-tom Scale(5[4,6]vs 5[4,5]),post-void residual urine volume(0[0,8]mL vs 0[0,7.5]mL)and quality of life(2[1,3]vs 2[1,3])(P＞0.05).The differences in the rates of postoperative stress urinary incontinence(2.1％vs 9.3％)and retrograde ejaculation(49.4％vs 74.5％)between the two groups were statistically significant(P＜0.05).Conclusion Bladder neck preservation during ThuLEP reduces the incidence of postoperative stress urinary incontinence and retrograde ejaculation.

Objective To assess the clinical efficacy and safety of rectal mucosal columnar suturing(Block technique)in combination with lauromacrogol injection for the treatment of female rectocele.Methods This retro-spective study analyzed 90 female patients with rectocele who were treated at Sir Run Run Hospital,Nanjing Medical University,from January 2022 to December 2023.Patients were categorized into three groups according to their surgical treatments:Block combined with lauromacrogol injection(BP group,n=30),Block alone(B group,n=30),and Procedure for Prolapse and Hemorrhoids(PPH,H group,n=30).The study compared general clinical data,perioperative indicators,Longo′s Obstructed Defecation Syndrome(Longo′s ODS)scores,the degree of recto-cele before and after surgery,anorectal manometry parameters,surgical efficacy,and perioperative complications among the three groups.Results The intraoperative blood loss in Group H was significantly higher compared to Groups B and BP(P<0.05).In terms of the 24-hour postoperative VAS score and hospital stay duration,Group BP demonstrated superior outcomes relative to Groups H and B(P<0.05).Preoperatively,there were no significant differences among the three groups regarding Longo′s ODS score,rectocele depth,resting anal pressure,or residual anal pressure(P>0.05).Postoperatively,Group BP exhibited significantly better Longo′s ODS scores and rectocele depth compared to Groups B and H(P<0.05).Although no significant differences were observed in postoperative resting and residual anal pressures among the three groups(P>0.05),the values in Group BP were closer to the normal range.The overall efficacy rate in Group BP was 93.3%,which was higher than the 73.3%in Group B and 66.7%in Group H(P<0.05).There was no significant difference in the complication rate across the three groups(P>0.05).Conclusions Block combined with lauromacrogol injection is a safe and effective treatment for female rectocele,demonstrating superior efficacy compared to both PPH and Block alone.This method not only effectively restores the physiological anatomy of the female rectum but also significantly improves clinical symptoms.